The 25 Biggest Pharmaceutical Stocks Trading in the US

The pharmaceutical industry is a critical sector in the US, playing a vital role in healthcare and research. With numerous companies vying for a piece of the market, it's essential to keep an eye on the top players. In this article, we'll explore the 25 biggest pharmaceutical stocks trading in the US, providing insights into their market performance and impact on the industry.

1. Johnson & Johnson (NYSE: JNJ) Johnson & Johnson is a household name in the pharmaceutical industry, known for its diverse range of products and innovative research. With a market capitalization of over $400 billion, JNJ is the largest pharmaceutical company in the world.

2. Pfizer Inc. (NYSE: PFE) Pfizer is another industry giant, specializing in biopharmaceuticals, vaccines, and consumer healthcare products. The company has a market capitalization of approximately $250 billion and has been at the forefront of developing new treatments and vaccines.

3. Merck & Co., Inc. (NYSE: MRK) Merck & Co. is a global healthcare leader, focusing on research-driven pharmaceuticals, biotechnology, and consumer healthcare products. With a market capitalization of around $200 billion, MRK is a key player in the industry.

4. AbbVie Inc. (NYSE: ABBV) AbbVie is known for its innovative biopharmaceuticals, including treatments for various chronic diseases. With a market capitalization of approximately $200 billion, ABBV is one of the top pharmaceutical companies in the US.

5. Eli Lilly and Company (NYSE: LLY) Eli Lilly and Company is a leader in biotechnology and pharmaceuticals, focusing on treatments for diabetes, cancer, and other chronic diseases. With a market capitalization of around $150 billion, LLY is a major player in the industry.

6. Amgen Inc. (NASDAQ: AMGN) Amgen is a biotechnology company specializing in innovative therapies for various diseases, including cancer, cardiovascular diseases, and neuroscience. With a market capitalization of approximately $200 billion, AMGN is a significant player in the industry.

7. Biogen Inc. (NASDAQ: BIIB) Biogen is a global leader in neuroscience research and development, focusing on treatments for neurological and neurodegenerative diseases. With a market capitalization of around $150 billion, BIIB is a key player in the industry.

8. Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) Vertex Pharmaceuticals is a biotechnology company specializing in the development of treatments for rare genetic diseases, including cystic fibrosis and sickle cell disease. With a market capitalization of approximately $100 billion, VRTX is a significant player in the industry.

9. Gilead Sciences Inc. (NASDAQ: GILD) Gilead Sciences is a biopharmaceutical company known for its antiviral treatments, including HIV/AIDS and hepatitis C. With a market capitalization of around $150 billion, GILD is a key player in the industry.

10. Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Regeneron is a biopharmaceutical company focused on the development of innovative treatments for various diseases, including rare genetic disorders, eye diseases, and inflammatory conditions. With a market capitalization of approximately $100 billion, REGN is a significant player in the industry.

11. Bristol Myers Squibb Co. (NYSE: BMY) Bristol Myers Squibb is a global biopharmaceutical company known for its research-driven approach to developing treatments for various diseases, including cancer, cardiovascular, and immunology conditions. With a market capitalization of around $150 billion, BMY is a key player in the industry.

12. Novartis AG (NYSE: NVS) Novartis is a global healthcare company known for its research-driven approach to developing innovative treatments for various diseases, including oncology, ophthalmology, and cardiovascular conditions. With a market capitalization of approximately $200 billion, NVS is a significant player in the industry.

13. Sanofi (NYSE: SNY) Sanofi is a global healthcare leader known for its research-driven approach to developing treatments for various diseases, including diabetes, cardiovascular, and neurological conditions. With a market capitalization of around $100 billion, SNY is a key player in the industry.

14. AstraZeneca PLC (NYSE: AZN) AstraZeneca is a global biopharmaceutical company known for its research-driven approach to developing treatments for various diseases, including oncology, cardiovascular, and respiratory conditions. With a market capitalization of approximately $100 billion, AZN is a significant player in the industry.

15. Celgene Corporation (NASDAQ: CELG) Celgene Corporation is a biopharmaceutical company known for its research-driven approach to developing treatments for various diseases, including cancer, immune-inflammatory conditions, and hematology. With a market capitalization of around $50 billion, CELG is a key player in the industry.

16. Incyte Corporation (NASDAQ: INCY) Incyte Corporation is a biopharmaceutical company known for its research-driven approach to developing treatments for various diseases, including oncology, inflammatory, and immunology conditions. With a market capitalization of approximately $50 billion, INCY is a significant player in the industry.

17. Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Regeneron is a biopharmaceutical company focused on the development of innovative treatments for various diseases, including rare genetic disorders, eye diseases, and inflammatory conditions. With a market capitalization of approximately $100 billion, REGN is a significant player in the industry.

18. Vertex Pharmaceuticals Inc. (NASDAQ: VRTX) Vertex Pharmaceuticals is a biotechnology company specializing in the development of treatments for rare genetic diseases, including cystic fibrosis and sickle cell disease. With a market capitalization of approximately $100 billion, VRTX is a significant player in the industry.

19. Gilead Sciences Inc. (NASDAQ: GILD) Gilead Sciences is a biopharmaceutical company known for its antiviral treatments, including HIV/AIDS and hepatitis C. With a market capitalization of around $150 billion, GILD is a key player in the industry.

20. Amgen Inc. (NASDAQ: AMGN) Amgen is a biotechnology company specializing in innovative therapies for various diseases, including cancer, cardiovascular diseases, and neuroscience. With a market capitalization of approximately $200 billion, AMGN is a significant player in the industry.

21. Biogen Inc. (NASDAQ: BIIB) Biogen is a global leader in neuroscience research and development, focusing on treatments for neurological and neurodegenerative diseases. With a market capitalization of around $150 billion, BIIB is a key player in the industry.

22. AbbVie Inc. (NYSE: ABBV) AbbVie is known for its innovative biopharmaceuticals, including treatments for various chronic diseases. With a market capitalization of approximately $200 billion, ABBV is one of the top pharmaceutical companies in the US.

23. Eli Lilly and Company (NYSE: LLY) Eli Lilly and Company is a leader in biotechnology and pharmaceuticals, focusing on treatments for diabetes, cancer, and other chronic diseases. With a market capitalization of around $150 billion, LLY is a major player in the industry.

24. Merck & Co., Inc. (NYSE: MRK) Merck & Co. is a global healthcare leader, focusing on research-driven pharmaceuticals, biotechnology, and consumer healthcare products. With a market capitalization of around $200 billion, MRK is a key player in the industry.

25. Pfizer Inc. (NYSE: PFE) Pfizer is another industry giant, specializing in biopharmaceuticals, vaccines, and consumer healthcare products. The company has a market capitalization of approximately $250 billion and has been at the forefront of developing new treatments and vaccines.

These 25 pharmaceutical stocks are at the forefront of the industry, driving innovation and improving healthcare outcomes for patients worldwide. By keeping an eye on these companies, investors can stay informed about the latest trends and developments in the pharmaceutical sector.

reprint: us energy stock

so cool！ ()